» Authors » Damien Bodet

Damien Bodet

Explore the profile of Damien Bodet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 105
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cochin T, Noal S, Stefan D, Bodet D, Rouger J, Dorbeau M, et al.
Front Oncol . 2025 Feb; 14:1505257. PMID: 39931211
Inflammatory myofibroblastic tumors (IMTs) are known to be associated with rearrangements of the anaplastic lymphoma kinase (ALK) gene. The treatment of this type of tumor includes systemic therapies such as...
2.
Filser M, Torrejon J, Merchadou K, Dufour C, Girard E, Bourneix C, et al.
Neuro Oncol . 2024 Dec; PMID: 39731757
Background: Medulloblastoma (MB) is one of the most prevalent embryonal malignant brain tumors. Current classification organizes these tumors into four molecular subgroups (WNT, SHH, Group 3, and Group 4 MB)....
3.
Courtel T, Lefresne M, Cartier I, Gerasse J, Gislier E, Proust S, et al.
Bull Cancer . 2024 Oct; 111(12):1095-1101. PMID: 39424515
The announcement of a cancer diagnosis is a crucial moment in the management of the disease, as it is the starting point for a relationship of trust between patient and...
4.
Benavides-Nieto M, Adam F, Martin E, Boussard C, Lagresle-Peyrou C, Callebaut I, et al.
J Clin Invest . 2024 Sep; 134(17). PMID: 39225097
The ubiquitously expressed small GTPase Ras-related protein 1B (RAP1B) acts as a molecular switch that regulates cell signaling, cytoskeletal remodeling, and cell trafficking and activates integrins in platelets and lymphocytes....
5.
Guerrini-Rousseau L, Masliah-Planchon J, Filser M, Tauziede-Espariat A, Entz-Werle N, Maugard C, et al.
Neurooncol Adv . 2024 Jul; 6(1):vdae075. PMID: 38962751
Background: pathogenic variants (PV) have been recently identified as the most frequent variants predisposing to Sonic Hedgehog (SHH) medulloblastomas (MB); however, guidelines are still lacking for genetic counseling in this...
6.
Bessis D, Bursztejn A, Morice-Picard F, Capri Y, Barbarot S, Aubert H, et al.
J Eur Acad Dermatol Venereol . 2024 Apr; 38(9):1818-1827. PMID: 38595321
Background: Data on dermatological manifestations of Costello syndrome (CS) remain heterogeneous and lack in validated description. Objectives: To describe the dermatological manifestations of CS; compare them with the literature findings;...
7.
Berlanga P, Ndounga-Diakou L, Aerts I, Corradini N, Ducassou S, Strullu M, et al.
JAMA Netw Open . 2023 Jul; 6(7):e2321568. PMID: 37399010
Importance: Innovative anticancer therapies for children, adolescents, and young adults are regularly prescribed outside their marketing authorization or through compassionate use programs. However, no clinical data of these prescriptions is...
8.
Maccari M, Wolkewitz M, Schwab C, Lorenzini T, Leiding J, Aladjdi N, et al.
J Allergy Clin Immunol . 2023 Jun; 152(4):984-996.e10. PMID: 37390899
Background: Activated phosphoinositide-3-kinase δ syndrome (APDS) is an inborn error of immunity (IEI) with infection susceptibility and immune dysregulation, clinically overlapping with other conditions. Management depends on disease evolution, but...
9.
Delehaye F, Deparis M, Buchbinder N, Bodet D, Minard V, Jean-Jacques B, et al.
Pediatr Blood Cancer . 2023 Jun; 70(10):e30497. PMID: 37335263
No abstract available.
10.
Merlin M, Schmitt E, Mezloy-Destracque M, Dufour C, Riffaud L, Puiseux C, et al.
J Neurooncol . 2023 May; 163(1):195-205. PMID: 37171700
Background: The HIT-SKK protocol is used for low/standard-risk medulloblastomas in young children with the aim to eliminate cranial irradiation and its neuropsychological (NP) sequelae. This therapy includes IV and intraventricular...